Breathe BioMedical
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Breathe BioMedical sits in the upper quartile of US sponsors by registered trial count (#3,661 of 15,751 sponsors by registered trial count).
Breathe BioMedical: 3 sponsored US clinical trials, 1 recruiting.
Breathe BioMedical sponsors 3 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting. The most-studied condition in this pipeline is Breast Cancer, with 1 trials.
Upper-quartile sponsor footprint
Breathe BioMedical sits in the upper quartile of the sponsor corpus (#3,661 of 15,751 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
3 total, page 1 of 1
Identifying Patterns in the Breath of Individuals With Breast Cancer
NCT06512350
Analysis of Volatile Chemicals in Lung Cancer Screen-Eligible Subjects Using Infrared Spectroscopy
NCT05174468
Breath Analysis in Early Stage Lung Cancer Using Infrared Spectroscopy
NCT04556435
Therapeutic Areas
What is open in the Breathe BioMedical pipeline
1 recruiting of 3 indexed (33% open).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Breast Cancer (1 trial), 0 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.